Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Vistagen Therapeutics' Q3 2025 earnings reveal progress on Phase 3 trials for social anxiety drug fasedienol, innovative therapies, and strong ...

Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's ...

THE first volume of this work, reviewed by Prof. R. A. Fisher in Nature of October 16, 1943, covered the subjects of frequency distributions and their properties ; theories of probability and ...

Construct financial models with decades of earnings statistics, ratios and valuation data - all exportable - to drive your trade ideas.

Future Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the impressive growth trajectory of the global advanced ...

The summative assessment consisting of statistical analyses and theory questions this will require students to demonstrate their knowledge and understanding of advanced statistics by carrying out ...

endpoints for patients with advanced gastric cancer. The disappointing outcome has led the company to halt plans for Phase 3 studies in this indication. Leap Therapeutics reported that while the ...

VISTA is currently enrolling. NCT04850118. Beacon Therapeutics is an ophthalmic gene therapy company founded to save and restore the vision of patients with a range of prevalent and rare retinal ...